ARCHIVES

Research teams link response to Iressa to mutations in EGF receptor.

This article is from The Cancer Letter archive.

Vol. 30 No. 18 | April 30, 2004

Download PDF Visit The Full Archive

Related Articles

In Surprising Result, Survey Of Centers Finds Little “Crisis” In Clinical Research

September 29, 1995

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

November 26, 2010

In Brief: ACA Executive Committee Votes to Move HQ Out Of New York; Davis Establishes Office In D.C.

April 17, 1987

Frelick To Receive ACCC Annual Award Will Leave NCI In July

March 6, 1987

New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial

September 24, 2010

In Brief: Hopkins Gets $10 Million for Directorships, to Dedicate New Clinical Cancer Building

October 22, 1999